ADAP
Adaptimmune Therapeutics Plc · HEALTHCARE
Orbimed Advisors LLC bought $5.0M of Adaptimmune Therapeutics Plc
Director
Bought$4,999,999
$4.20Price
1,190,476Shares
+24%Stake
What ADAP did for a copier
Prices for ADAP after this filing aren't in yet.
Orbimed Advisors LLC's record
35 other buys with 3 months of prices since 2016: on average −12.5% against the S&P 500, and 12 of 35 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Mar 27. Filed Tue, Mar 28, 6:48 PM ET, after the close. Not investment advice.